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In an earlier paper of this series (Tarui, 1963) , zinc metabolism was discussed of depancreatized dogs and alloxan diabetic rabbits. It was demonstrated that metabolic disturbances in the diabetic state are always followed by a persistent increase in urinary zinc excretion.
An attempt was made in the present study to clarify relations between the magnitude of zincuria and clinical findings in diabetic patients.
MATERIALS
AND METHODS (Fairhall, 1929; McCance and Widdowson, 1942; Wolff, 1956; Vallee at al., 1957; Tarui, 1959 The technic employed for the determination of urine zinc has been described in another paper (Tarui, 1963) . Serum zinc determinations were performed on fasting venous blood. The venous blood was drawn without stasis or hemolysis into a metal-free syringe. The serum was allowed to separate and stored. A 3 cc aliquot of serum was ashed with sulphuric acid and perchloric acid and the zinc contained was determined with the same method as employed for urine zinc. Blood sugar determination was carried out by the Somogyi method (Somogyi, 1952) .
RESULTS
Urinary excretion of zinc in patients with diabetes raellitus There is also a highly significant difference in the concentration of urine zinc between diabetic and normal subjects. Thus a concept is obtained that an increased urinary zinc excretion in diabetic patients is not necessarily referred to the polyuria in diabetic subjects.
Day-to-day variations in zinc excretion in patients with diabetes mellitus
As shown in Table 2 , series of figures of urine zinc during several consecutive days were all within a very short range. This result is in accord with the observation by Vallee et al. (1957) for a normal adult subject. It may be concluded that fluctuations in urinary excretion of zinc are considerably slight not only in a normal individual but in a patient such as diabetic. It was verified that such constant value of urine zinc in a diabetic was not subjected to a change within a short period under the influence of a rapid decrease of urine glucose due to a low carbohydrate intake (Fig. 1) . This indicates that urine zinc is not directly related to urine glucose. A possible explanation for the constancy of urine zinc value will be discussed later.
Correlations between urine zinc and severity of diabetes Since a diabetic individual shows an increase in urine zinc with a slight day- to-day variation, correlations between urine zinc and the severity of diabetes are to be a matter of consideration. In the present report fasting blood glucose was adopted as index of the severity of diabetes.
As shown in Figure 2 , an appreciable correlationship was observed between urine zinc and fasting blood glucose (P<0.001).
It is indicated that the magnitude of an increase of zinc excretion may reflex the severity of diabetes.
Effect of treatment of diabetes upon urinary zinc excretion
Provided that an increase of urine zinc is referred to the augmentation of metal-complexing metabolites under diabetic conditions, control of diabetes is very likely to result in a significant change in zinc excretion.
The results of treatment with insulin or antidiabetic sulfonylurea upon urine zinc are shown in Figure 3 . Urinary zinc excretion tended to show a gradual decrease as control of diabetes advanced.
This finding is essentially in accord with the results reported in Part II of this series indicating that an increased zinc excretion returns to normal following a spontaneous remission in an alloxan diabetic rabbit.
After the treatment, however, most patients still excreted a little larger amount of zinc than normal subjects, forming a contrast to the above case of alloxan diabetes which showed a remission. Such excretion is presumably due to an imperfect control of metabolic disorders of diabetes.
Serum zinc in patients with diabetes mellitus
The results of serum zinc determinations are presented in Figure  4 . The 
DISCUSSION
The present data, combined with those reported previously (Tarui, 1963) , confirm the existence of marked changes in zinc metabolism under diabetic conditions.
The changes were demonstrated in depancreatized dogs, alloxan diabetic rabbits, and diabetic patients. It is of a special interest that the amount of urine zinc of diabetics is individually not so different on a daily basis and that a linear relationship is found between the magnitude of an increase of zinc excretion and the severity of diabetes. McCance and Widdowson (1942) elucidated that the amount of urinary zinc excretion is not varied with the intake of zinc by muscle, nor is it appreciably raised by intravenous injection. It was deduced in the preceding paper that zinc is distributed in a loosely bound form far more abundantly than iron or copper and the magnitude of an increase in urine zinc accurately reflexes the augmentation of what is possessed with a high metal-complexing capacity in the living body. Here it must be admitted that the urinary excretion of zinc is entirely dependent on an extent of prechelation. It is reasonably considered that the formation of endogenous chelating agents do not change so much, so long as the systemic metabolism remains unchanged. This consideration possibly constitutes a major factor responsible for the constancy in urinary zinc excretion.
Experiments
with radiozinc were carried out in our laboratory, suggesting that a principal zinc elimination occurs via the pancreas or the alimentary tract (Tarui, 1958) . Therefore, an increased urinary excretion of zinc would result in a decrease of the need for the principal route. This is one of the most valid reasons in explaining cases in which a marked increase in urinary zinc excretion is not necessarily accompanied by a significant decrease in serm zinc. We are supported to assume that most of the changes observed in the islets of Langerhans of diabetic patients may be a result of long-standing diabetic conditions rather than an etiological factor.
Metahypophyseal diabetes is only one instance out of many that might be cited. Since several chelating agents were designated as diabetogenic substances (Okamoto, 1949; Kadota, 1950) and other chelating agents were found to influence an insulin secretion (Ninomiya, 1962) , special attention should be paid to the evidence of accumulation of metabolic products which possess chelating properties following metabolic derangements in diabetes. 
